Lymphocyte proliferation in immune-mediated diseases
Authors:
- 1 September 2009
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 30 (9) , 430-438
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency—lessons learned from monogenic disorders in mice and menCurrent Opinion in Immunology, 2008
- IL-21 signaling is critical for the development of type I diabetes in the NOD mouseProceedings of the National Academy of Sciences, 2008
- Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityProceedings of the National Academy of Sciences, 2008
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008
- Defective positive selection results in T cell lymphopenia and increased autoimmune diabetes in ADAP‐deficient BDC2.5‐C57BL/6 miceEuropean Journal of Immunology, 2008
- CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunityProceedings of the National Academy of Sciences, 2008
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology, 2008
- T cell immune reconstitution following lymphodepletionSeminars in Immunology, 2007
- Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory diseaseProceedings of the National Academy of Sciences, 2007
- CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organsNature, 2006